drugset
drugset / Trial / NCT05470075

A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teeth Removal Surgery.

NCT05470075 ↗

Phase 2 Terminated 110 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind, dose finding, parallel controlled with active drug and placebo, phase II clinical trial, and the purpose of the study is to evaluate the efficacy and safety of HR18042 tablets for postoperative analgesia after impacted teeth removal surgery.

Timeline

Start
2022-08-11
Primary completion
2022-12-16
Completion
2022-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject HR18042 Unknown 175 mg Oral
Subject HR18042 Unknown 225 mg Oral
Subject HR18042 Unknown 275 mg Oral
Comparator Tramadol Other / unclassified 100 mg Oral

Indications

No indication recorded.